Story perspectives

Breakthroughs in Immunotherapy: China Leads, New Targets Unveiled

10/22/2025

Summary

Research Advances Immunotherapy

A bibliometric study on lung cancer immunotherapy resistance notes a decade of progress and rising publications, especially from China.
Lunit's AI solution showed predictive capability for immune checkpoint inhibitor responses in colorectal cancer, signaling a need for pharmaceutical collaboration.
In diffuse large B-cell lymphoma, researchers mapped seven microenvironments, suggesting new therapeutic targets.
Overweight patients experienced more immune-related adverse events during immunotherapy, underscoring the importance of body mass index in treatment.

Summary

Study Explores Osteosarcoma

A study analyzed 26 paired osteosarcoma tissue samples and adjacent normal tissues from Yancheng First Hospital in China to explore clinical correlations and survival associations.
Histopathological confirmation and documentation of clinicopathological parameters were completed for all samples.
A xenograft mouse model using HOS cells was established to monitor tumor growth.
The study integrated gene expression datasets and protein–protein interaction analysis.
Procedures adhered to ethical guidelines and institutional regulations.

1 of 2

Research Advances Immunotherapy

A bibliometric study on lung cancer immunotherapy resistance notes a decade of progress and rising publications, especially from China.
Lunit's AI solution showed predictive capability for immune checkpoint inhibitor responses in colorectal cancer, signaling a need for pharmaceutical collaboration.
In diffuse large B-cell lymphoma, researchers mapped seven microenvironments, suggesting new therapeutic targets.
Overweight patients experienced more immune-related adverse events during immunotherapy, underscoring the importance of body mass index in treatment.

1 / 2